TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Pharma Nord ApS
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
749,380
|
666,079
|
657,610 |
| Earnings before taxes |
60,518
|
38,743
|
64,463 |
| Total assets |
624,108
|
635,865
|
668,945 |
| Current assets |
283,889
|
336,684
|
389,859 |
| Current liabilities |
304,973
|
298,383
|
292,842 |
| Equity capital |
220,713
|
239,052
|
273,900 |
| - share capital |
308
|
298
|
299 |
| Employees (average) |
150
|
150
|
150 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
35.4%
|
37.6%
|
40.9% |
| Turnover per employee |
4,996
|
4,441
|
4,384 |
| Profit as a percentage of turnover |
8.1%
|
5.8%
|
9.8% |
| Return on assets (ROA) | |||
| Current ratio |
93.1%
|
112.8%
|
133.1% |
| Return on equity (ROE) |
27.4%
|
16.2%
|
23.5% |
| Change turnover |
60,517
|
11,838
|
-46,006 |
| Change turnover % |
9%
|
2%
|
-7% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.